Selected publications
- Distinctive clinical presentation of a NF-1 patient with loss of heterozygosity of PTCH in his epithelial tumors. International journal of dermatology. 44:831-836. 2005 Academic Article GET IT
-
Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.
The Journal of infectious diseases.
191:686-693.
2005
Academic Article
GET IT
Times cited: 13 -
Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
Archives of dermatology.
140:584-588.
2004
Academic Article
GET IT
Times cited: 9 -
In vivo assessment of antiviral reactivity in chronic HIV infection.
HIV clinical trials.
1:16-22.
2000
Academic Article
GET IT
Times cited: 12 -
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.
HIV clinical trials.
1:1-15.
2000
Academic Article
GET IT
Times cited: 45 - Immunity restoration of immunity with interleukin-2 therapy. The AIDS reader. 9:563-572. 1999 Academic Article
-
Interleukin-2 infusions in HIV-infected patients.
The New England journal of medicine.
1260-1261.
1997
Comment
GET IT
Times cited: 4 - Interleukin-2 therapy for HIV* individuals. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 44:250a. 1996 Academic Article
-
Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.
Proceedings of the National Academy of Sciences of the United States of America.
93:10405-10410.
1996
Academic Article
GET IT
Times cited: 150